AIIMS scientists describe new type of diabetes afflicting the brain

Sunday, February 19, 2017

by IMT News Desk

New Delhi: In a groundbreaking study, scientists at the All India Institute of Medical Sciences (AIIMS), New Delhi have described a new type of diabetes they term as “Diabetes Type 4”.

Dr Tanuj Dada

Dr Tanuj Dada

This new discovery is expected to open a new field of therapy for glaucoma and neurodegenerative diseases.

According to Dr Muneeb Faiq and Dr Tanuj Dada, scientists behind this study, this diabetes is uniquely different from the one accompanied with high blood glucose levels because it afflicts the brain and ocular tissues specifically.

Dr Faiq is a clinical researcher working on glaucoma, neurodegeneration and diabetes and Dr Dada is professor of ophthalmology at AIIMS, New Delhi.

Diabetes Type 1 and 2 are accompanied with high levels of glucose in the blood but according to the scientists, Diabetes Type 3 (Alzheimer’s disease) and Diabetes Type 4 (glaucoma) are restricted to the brain and ocular tissues respectively.

Dr Faiq and Dr Dada have also made a case for Parkinson’s disease to be referred as Diabetes Type 5.

Glaucoma is the leading cause of irreversible blindness with more than 65 million sufferers worldwide. It is accompanied with severe compromise in the quality of life, stress, depression, higher propensity to accidents and cognitive deficit in addition to huge economic burden. There is no cure for this malady and the only treatment currently available is lowering of eye pressure with medicines and/or surgery. The disease continues to progress even after controlling the pressure inside the eyes. That is why this disorder is also called “Sneak thief of sight”.

With a view of developing an effective remedy for glaucoma, scientists are busy in cutting edge research to know the nature and pathogenesis of this disorder. But, as of now, no effective theory to cover all the aspects of this disease has been found.

The research carried out by Dr Faiq and Dr Dada is likely to satisfy this long sought goal, which may ultimately help in developing an effective cure. Their findings have opened new doors towards understanding glaucomatous vision loss and immediately suggest measures for prevention and effective treatment.

According to the paper published in Current Molecular Medicine, diabetes can afflict the brain and can exist independent of the other already known types of diabetes. This brain diabetes may or may not be accompanied with high blood sugar. Brain is a separate compartment and much of its metabolism is independent of systemic metabolism.

Based on this idea, the researchers claim that brain can suffer from diabetes (independent of regular type 1 and type 2 forms). If the diabetes affects the cerebral part it becomes Alzheimer’s disease (Diabetes Type 3) and if it afflicts the visual pathway it becomes glaucoma (Diabetes Type 4).

The investigators argue that the whole concept is based on insulin signalling and what they have termed “Insulin Hypofunctionality”. Proper insulin signalling is important for the survival of neurons, particularly Retinal Ganglion Cells (cells that die in glaucoma). Loss of healthy insulin signalling causes “Insulin Hypofunctionality” which leads to the activation of many disease pathways that finally culminate in irreversible vision loss.

The discovery of glaucoma being Diabetes Type 4 is likely to make a paradigm shift in the understanding of this disorder and identifies brain as the potential diagnostic and therapeutic target in glaucoma. In the light of this discovery, insulin therapy (restoration of insulin signalling) is a promising therapeutic intervention in glaucoma as well as in Alzheimer’s disease and possibly Parkinson’s disease.

Categories: Ophthalmology, RESEARCH

Tags: , , , , , , , , , , , , , , , ,

  More from Ophthalmology

AIIMS scientists describe new type of diabetes afflicting the brain


New research may lead to non-surgical cataract treatment


After blindness, the adult brain can learn to see again


‘Made in India stem cell therapy for blindness’ receives global validation


‘Crispr’ gene editing technique may treat inherited blindness


Indian engineer’s device determines extent of eye injury

1 Comment »

Comment by Mike
2018-10-18 08:01:59

The actual study was published by Dr. Faiq and his group back in 2014. The Nature paper you are citing was published in 2015. And these two papers work on two different diseases. AIIMS group has identified diabetes like pathology in glaucoma and hence they call in diabetes type 4 while as Salk group has identified a form of fat depletion mediated by regulatory T cells associated with insulin resistance and hence they call it diabetes type 4. But effectively diabetes type 4 was first reported by AIIMS scientists and not the Salk group. though we don’t know whether any of these diseases should be called yet another form of diabetes but it will be wrong to say that Salk reported it while AIIMS did not. AIIMS reported it first.

It will be important to mention that Faiq group has made many discoveries including the deciphering of the mechanism of Zika virus mediated Brain defects. His group also developed novel stress reduction based methods for glaucoma and various neurodegenerative diseases. thousands of people around the world have benefited from his effective techniques and innovative science.

 
Name (required)
E-mail (required - never shown publicly)
URI
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.